Should You Buy the Dip in Archer Aviation Stock?
Key Points
-
Archer reached an all-time high stock price of roughly $13 in late 2025, but so far this year shares have struggled.
-
Investors are beginning to demand realistic revenue growth and a path to profitability as opposed to rewarding an ambitious vision.
-
While Archer’s current price of $5.50 looks tempting,
» Read more about: Should You Buy the Dip in Archer Aviation Stock? »
Read MoreWhy These 3 Red Hot Tech Stocks Keep Climbing
Several stocks have seen increased interest as of late, including Micron MU, Alphabet GOOGL, and SanDisk SNDK. Given the recent spike in interest, let’s take a closer look at how each presently stacks up and what’s been driving the positivity behind each.
SanDisk Maintains Momentum
SanDisk shares have been melting higher in 2026 as its critical role in AI infrastructure becomes increasingly recognized.
» Read more about: Why These 3 Red Hot Tech Stocks Keep Climbing »
Read MoreMastering options trading from zero to pro
Options trading can provide leverage, income potential, and portfolio protection — but it demands a clear grasp of the mechanics, strategies, and brokerage requirements. From understanding calls and …
» Read more about: Mastering options trading from zero to pro »
Read MoreChoosing the right broker for options trading
Charles Schwab and Interactive Brokers both offer strong options trading capabilities, but they cater to different trader profiles. Schwab shines for U.S.-focused traders who value education, …
» Read more about: Choosing the right broker for options trading »
Read MoreWhy Axsome Therapeutics Stock Jumped Over 20% in April
Axsome Therapeutics (AXSM 0.59%) has been growing sales rapidly with its Auvelity antidepressant. The biopharmaceutical company focuses on developing therapies for central nervous system (CNS) disorders.
Auvelity, launched in late 2022, has been approved to treat major depressive disorder (MDD) in adults, and sales have been growing quickly.
» Read more about: Why Axsome Therapeutics Stock Jumped Over 20% in April »
Read MoreThe Burst
Why This Might Still Be a Long-Term Winner
Leonardo DRS is one of those under-the-radar defense companies powering some of the most advanced military systems in the world. From sensors and tactical computing to ruggedized networking gear and combat vehicles, DRS builds much of the U.S. military’s digital backbone.
Shares are up more than 20% over the past year but have slipped nearly double digits since Q3 earnings.
» Read more about: Why This Might Still Be a Long-Term Winner »
Read MoreThe Ivy
Is This The Most Reliable Passive-Income Engine?
Among the more compelling income opportunities in this corner of the market is Ares Capital, a business development company offering a nearly double-digit yield supported by one of the strongest credit platforms in the country.
That yield isn’t the main reason sophisticated investors pay attention, though. What distinguishes Ares Capital is the durability of the system generating those payouts.
» Read more about: Is This The Most Reliable Passive-Income Engine? »
Read MoreThe Spotlight
Is This Dental Stock a Stunning Bargain?
Dentsply Sirona (NASDAQ: XRAY), one of the world’s largest makers of dental equipment and supplies, was created in 2016 when Dentsply merged with Sirona Dental Systems.
Fast forward to today, and the company is battling falling sales, mounting losses, and a stock price that has been hammered by more than 44% in the past year.
» Read more about: Is This Dental Stock a Stunning Bargain? »